Results 111 to 120 of about 7,490 (202)

Novel cruzain inhibitors for the treatment of Chagas' disease. [PDF]

open access: yes, 2012
The protozoan parasite Trypanosoma cruzi, the etiological agent of Chagas' disease, affects millions of individuals and continues to be an important global health concern.
Arkin, Michelle R   +6 more
core   +1 more source

The trypanocidal activity of the alkaloid oliverine involves inhibition of DNA synthesis [PDF]

open access: yes, 2010
The Trypanosoma cruzi parasite is an etiologic agent of the American trypanosomiasis called Chagas disease. This pathology affects more than 24 million persons and represents one of the most important public health problems in Latin America.
Garro, Hugo Alejandro   +5 more
core  

Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib [PDF]

open access: yes, 2009
The proteasome inhibitor and anti-cancer drug bortezomib was tested for in vitro activity against bloodstream forms of Trypanosoma brucei. The concentrations of bortezomib required to reduce the growth rate by 50% and to kill all trypanosomes were 3.3 nM
Steverding Dietmar, Wang Xia
core   +2 more sources

Insights into Chagas treatment based on the potential of bacteriocin AS-48

open access: yesInternational Journal for Parasitology: Drugs and Drug Resistance, 2019
Chagas disease caused by the protozoan parasite Trypanosoma cruzi represents a significant public health problem in Latin America, affecting around 8 million cases worldwide.
Rubén Martín-Escolano   +6 more
doaj   +1 more source

Chagas' disease: an update on immune mechanisms and therapeutic strategies [PDF]

open access: yes, 2010
The final decade of the 20th century was marked by an alarming resurgence in infectious diseases caused by tropical parasites belonging to the kinetoplastid protozoan order.
Abel   +125 more
core   +1 more source

Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease

open access: yesFrontiers in Pharmacology, 2019
Leishmaniasis and Chagas disease cause great impact on social and economic aspects of people living in developing countries. The treatments for these diseases are based on the same regimen for over 40 years, thus, there is an urgent need for the ...
Roberval Nascimento Moraes Neto   +5 more
doaj   +1 more source

Ligand-Based Virtual Screening and Molecular Docking of Benzimidazoles as Potential Inhibitors of Triosephosphate Isomerase Identified New Trypanocidal Agents. [PDF]

open access: yesInt J Mol Sci, 2022
Vázquez-Jiménez LK   +11 more
europepmc   +1 more source

The biological in vitro effect and selectivity of aromatic dicationic compounds on Trypanosoma cruzi

open access: yesMemorias do Instituto Oswaldo Cruz, 2010
Trypanosoma cruzi is a parasite that causes Chagas disease, which affects millions of individuals in endemic areas of Latin America. One hundred years after the discovery of Chagas disease, it is still considered a neglected illness because the available
Cristiane França da Silva   +5 more
doaj   +1 more source

Design and Synthesis of Bis-Chalcones as Curcumin Simplified Analogs and Assessment of Their Antiproliferative Activities Against Human Lung Cancer Cells and Trypanosoma cruzi Amastigotes

open access: yesPharmaceuticals
Background: Anticancer therapies represent the primary treatment option for a significant number of cancer patients globally; however, many of these treatments are associated with severe side effects as they target molecular structures present in both ...
Gabriela Alves de Souza   +18 more
doaj   +1 more source

The Combination of Vitamin K3 and Vitamin C Has Synergic Activity against Forms of Trypanosoma cruzi through a Redox Imbalance Process.

open access: yesPLoS ONE, 2015
Chagas' disease is an infection that is caused by the protozoan Trypanosoma cruzi, affecting millions of people worldwide. Because of severe side effects and variable efficacy, the current treatments for Chagas' disease are unsatisfactory, making the ...
Vânia Cristina Desoti   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy